See more : Emira Property Fund Limited (EMI.JO) Income Statement Analysis – Financial Results
Complete financial analysis of ReWalk Robotics Ltd. (RWLK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of ReWalk Robotics Ltd., a leading company in the Medical – Devices industry within the Healthcare sector.
- Lentex S.A. (LTX.WA) Income Statement Analysis – Financial Results
- Patrick Industries, Inc. (PATK) Income Statement Analysis – Financial Results
- Noble Mineral Exploration Inc. (NOB.V) Income Statement Analysis – Financial Results
- Jumbo S.A. (BELA.AT) Income Statement Analysis – Financial Results
- Alpen Co.,Ltd. (3028.T) Income Statement Analysis – Financial Results
ReWalk Robotics Ltd. (RWLK)
About ReWalk Robotics Ltd.
ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke in the clinical rehabilitation environment; and MyoCycle and MediTouch tutor movement biofeedback devices for use at home or in clinic. It markets and sells its products directly to third party payers; institutions, including rehabilitation centers; and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Ilit, Israel.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 13.85M | 5.51M | 5.97M | 4.39M | 4.87M | 6.55M | 7.75M | 5.87M |
| Cost of Revenue | 9.40M | 3.61M | 3.06M | 2.20M | 2.15M | 3.72M | 4.65M | 5.13M |
| Gross Profit | 4.45M | 1.91M | 2.90M | 2.19M | 2.73M | 2.83M | 3.10M | 736.00K |
| Gross Profit Ratio | 32.14% | 34.57% | 48.66% | 49.83% | 55.94% | 43.16% | 40.00% | 12.54% |
| Research & Development | 4.15M | 4.03M | 2.94M | 3.46M | 5.35M | 7.35M | 6.04M | 9.03M |
| General & Administrative | 10.00M | 7.13M | 5.63M | 4.98M | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 13.92M | 9.84M | 6.99M | 5.75M | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 23.92M | 16.98M | 12.62M | 10.73M | 11.43M | 14.69M | 19.05M | 22.15M |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 28.07M | 21.01M | 15.56M | 14.19M | 16.77M | 22.04M | 25.09M | 31.18M |
| Cost & Expenses | 37.47M | 24.61M | 18.62M | 16.40M | 18.92M | 25.76M | 29.75M | 36.31M |
| Interest Income | 1.35M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -1.00 |
| Interest Expense | 20.00K | 22.00K | 25.00K | 907.00K | 1.53M | 2.42M | 2.48M | 2.01M |
| Depreciation & Amortization | 1.85M | 202.00K | 266.00K | 285.00K | 321.00K | 463.00K | 642.00K | 696.00K |
| EBITDA | -21.77M | -18.90M | -12.39M | -11.73M | -13.72M | -18.79M | -21.48M | -29.79M |
| EBITDA Ratio | -157.10% | -343.35% | -208.30% | -267.29% | -281.70% | -286.49% | -275.38% | -506.82% |
| Operating Income | -23.61M | -19.10M | -12.66M | -12.00M | -14.05M | -19.21M | -21.99M | -30.44M |
| Operating Income Ratio | -170.43% | -346.62% | -212.12% | -273.25% | -288.28% | -293.57% | -283.66% | -518.67% |
| Total Other Income/Expenses | 1.47M | 0.00 | 13.00K | -921.00K | -1.50M | -2.47M | -2.61M | -2.06M |
| Income Before Tax | -22.15M | -19.10M | -12.64M | -12.93M | -15.54M | -21.68M | -24.60M | -32.50M |
| Income Before Tax Ratio | -159.85% | -346.62% | -211.90% | -294.22% | -318.98% | -331.25% | -317.27% | -553.76% |
| Income Tax Expense | -12.00K | 467.00K | 94.00K | 51.00K | 7.00K | -5.00K | 119.00K | 3.00K |
| Net Income | -22.13M | -19.57M | -12.74M | -12.98M | -15.55M | -21.68M | -24.72M | -32.50M |
| Net Income Ratio | -159.76% | -355.09% | -213.48% | -295.38% | -319.13% | -331.17% | -318.81% | -553.81% |
| EPS | -2.59 | -2.20 | -1.86 | -5.74 | -18.90 | -103.04 | -213.98 | -431.63 |
| EPS Diluted | -2.59 | -2.20 | -1.86 | -5.74 | -18.90 | -103.04 | -213.98 | -431.63 |
| Weighted Avg Shares Out | 8.53M | 8.91M | 6.85M | 2.25M | 823.33K | 210.36K | 115.51K | 75.30K |
| Weighted Avg Shares Out (Dil) | 8.53M | 8.91M | 6.85M | 2.25M | 823.33K | 210.36K | 115.51K | 75.30K |
ReWalk Robotics Expands Direct Sales Coverage to Canada
ReWalk Robotics Ltd. to Present at Sidoti Virtual Investor Conference on January 17
First ReWalk Personal Exoskeleton Claim Paid by Medicare
ReWalk Robotics Presents on Personal Exoskeleton Pricing at Medicare Public Meeting
Penny Stock Powerhouses: 7 Picks Poised for Explosive Growth
ReWalk Robotics Demonstrates AI Autonomous Decision Making in Next Generation Exoskeleton Prototype
7 Cheap Stocks to Buy Now if You Have $100 to Spend: November Edition
ReWalk Robotics Ltd. (RWLK) Q3 2023 Earnings Call Transcript
ReWalk Robotics Reports Third Quarter 2023 Financial Results
New Bill Facilitates Veteran Access to Powered Exoskeletons
Source: https://incomestatements.info
Category: Stock Reports